Birmingham comprehensive high impact prevention project 2 (b-CHIP2). : diagnosing, treating, and preventing HIV for black MSM. - jefferson county, alabama, the setting for this proposed…

Birmingham comprehensive high impact prevention project 2 (b-CHIP2). : diagnosing, treating, and preventing HIV for black MSM. - jefferson county, alabama, the setting for this proposed community-based HIV prevention project, consistently has the highest number of new HIV diagnoses and STD diagnoses (including gonorrhea, chlamydia, and primary and secondary syphilis) in the state, which are disproportionately experienced by black men who have SEX with men (MSM), this project?s target population. Focusing on reducing new HIV infections and improving personal and public health by getting black MSM tested and linked to/engaged in HIV medical care and essential support services in this high-burden area of the state, the current project, birmingham-comprehensive high impact prevention-project 2 (b-CHIP2), leverages years of partnership between birmingham aids outreach (BAO), the oldest HIV service organization in state of alabama and the aletheia house, a leading expert on HIV testing and prevention services for black MSM, housing services, and substance use treatment services. Building on the successes of our previous CDC-funded, high-impact HIV prevention program, b-chip, under PS-15-1502, b-CHIP2 has multiple short-, intermediate-, and long-term goals that align with the four pillars of the EHE (diagnose, treat, prevent, respond). The following short term outcomes and corresponding goals will be evaluated during the project performance period: (1) increasing the number and percentage of black MSM tested for HIV to a minimum of 750 tests annually and diagnosing 15 black MSM with HIV per year (2.0%), (2) increasing the percentage of integrated HIV testing events in which clients are able to receive STD tests events that specifically target black MSM (including chlamydia, syphilis, and gonorrhea), as well as trichomoniasis, hepatitis c, and covid-19 by 50 percent annually over three large-scale and 12 monthly events per year, for a total of 2,250 integrated tests over five years, (3) increasing the number and percentage of black MSM with newly diagnosed HIV who are linked to h IV medical care and receiving art within 30 days of diagnosis by linking a minimum of 90% of 15 black MSM (n=14) to HIV medical care using anti-retroviral treatment and access to services (artas), (4) increasing the number and percentage of previously diagnosed, not-in-care black MSM who are linked to HIV medical care and receiving art within 30 days of identification by linking a minimum of 90% of previously diagnosed, not-in-care black MSM (n=9) to HIV medical care using artas, (5) increasing access to prep and npep by referring at least 90% of black MSM in the program at high risk for acquiring HIV to prep or npep services, as appropriate, and in accordance with CDC guidelines, (6) increasing availability of condoms (both male and female condoms) by offering free condoms to 100% of black MSM in the program with HIV (including both newly and previously diagnosed) and 100% of black MSM in the program at risk for acquiring HIV, equal to 10,000 number of condoms distributed per year.